Substance Use Disorder

Enter your email to check out this complicated case!

In this CME article, learn how best to provide end-of-life care to patients with psychiatric disorders.

Learn more about the latest research related to 9/11 trauma and other psychiatric comorbidities.

When psychiatrists fully embrace psychopharmacological interventions as integral components of addiction treatment, patients can begin a journey toward sustainable recovery.

Tomorrow, August 31, is Overdose Awareness Day. What can you be doing to help prevent overdose deaths?

In this CME article, learn more about how to assess the impact of alcohol and cannabis use on anxiety treatment outcomes, recognizing potential adverse effects and interactions.

Cannabis use during adolescence can profoundly impact brain development.

Social media is here to stay, and its use must be a consideration in the treatment of psychiatric conditions, particularly substance use disorder and alcohol use disorder.

Learn more about cannabis use and social media addiction in this month's Special Report!

What influence do legislation and social-based decisions have on individual mental health, like in the case of drag performers?

Guidelines from the World Health Organization's Mental Health Gap Action Program support nonspecialist health workers providing evidence-based treatments in underresourced regions.

The FDA has issued a complete response letter to Orexo for OX124, a high-dose naloxone nasal spray for opioid overdose reversal.

What is new in research on alcohol use disorder?

To expertly utilize polypharmacy, it is imperative that clinicians stay abreast of new literature, check for drug-drug interactions, and be aware of emerging trends in drug use.

Inhalant use disorder is characterized by the intentional inhalation of volatile substances for their psychoactive effects. Learn more about how to help manage this disorder.

Cannabis withdrawal syndrome impacts approximately half of those who use it regularly. How can you help patients cease cannabis use?

Review tapering challenges and strategies for benzodiazepines in this Special Report article.

With cannabis legalization increasing in the United States, so too are the issues surrounding cannabis access, usage, and use disorders. State by state, take a peek at some of the issues and updates surrounding cannabis.

We're highlighting issues in addiction in our special Digital Supplement! Learn more here.

An analysis presented at the ASCP Annual Meeting explored the safety and tolerability of the treatment for alcohol and tobacco use disorders.

Write to us now for a chance to be featured in our upcoming Special Report on Addiction.

Here’s how an integrated psychosocial and pharmacologic approach can enhance SUD treatment.

This 2024 APA Annual Meeting poster documented the abuse potential of benzodiazepines and tapering challenges.

Petros Levounis, MD, MA, talks addiction, buprenorphine, his year as president of the APA, and more at the 2024 Annual Meeting.

Use this protocol, presented at the 2024 APA Annual Meeting, in patients with cannabis use disorder to bolster likelihood of cannabis cessation or reduction in use.

A look at the theme for the 2024 American Psychiatric Association Annual Meeting.

How can psychiatric clinicians improve outcomes for this unique patient population?

How can novel technologies help address stigma and improve care for patients with SUDs?

"In the face of such a pervasive crisis, being present for those with addiction can ignite hope and foster healing."

What are the most effective approaches to SUD treatment in this unique patient population?